DK0733207T3 - Fremgangsmåder til diagnose af allergi og screening af anti-allergi-terapeutika - Google Patents

Fremgangsmåder til diagnose af allergi og screening af anti-allergi-terapeutika

Info

Publication number
DK0733207T3
DK0733207T3 DK95905357.0T DK95905357T DK0733207T3 DK 0733207 T3 DK0733207 T3 DK 0733207T3 DK 95905357 T DK95905357 T DK 95905357T DK 0733207 T3 DK0733207 T3 DK 0733207T3
Authority
DK
Denmark
Prior art keywords
patient serum
allergen
pct
host cells
allergy
Prior art date
Application number
DK95905357.0T
Other languages
Danish (da)
English (en)
Inventor
Wai Fei David Tai
John Lowe
Paula Jardieu
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0733207T3 publication Critical patent/DK0733207T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK95905357.0T 1993-12-10 1994-12-09 Fremgangsmåder til diagnose af allergi og screening af anti-allergi-terapeutika DK0733207T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16543693A 1993-12-10 1993-12-10

Publications (1)

Publication Number Publication Date
DK0733207T3 true DK0733207T3 (da) 1998-04-20

Family

ID=22598886

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95905357.0T DK0733207T3 (da) 1993-12-10 1994-12-09 Fremgangsmåder til diagnose af allergi og screening af anti-allergi-terapeutika

Country Status (10)

Country Link
US (1) US5714338A (ja)
EP (1) EP0733207B1 (ja)
JP (1) JP3507852B2 (ja)
AT (1) ATE157455T1 (ja)
CA (1) CA2176811C (ja)
DE (1) DE69405251T2 (ja)
DK (1) DK0733207T3 (ja)
ES (1) ES2108566T3 (ja)
GR (1) GR3025089T3 (ja)
WO (1) WO1995016203A2 (ja)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9526599D0 (en) 1995-12-28 1996-02-28 Sandoz Ltd Elisa test system
DE19643427C1 (de) * 1996-10-22 1998-02-12 Bundesrep Deutschland Verfahren zur Bestimmung von Allergenen in der Luft
US6165799A (en) * 1996-12-10 2000-12-26 Heska Corporation Detection of anti-Fc.sub.ε R autoantibodies in asthmatics
US7122636B1 (en) * 1997-02-21 2006-10-17 Genentech, Inc. Antibody fragment-polymer conjugates and uses of same
US6060326A (en) * 1997-04-07 2000-05-09 Heska Corporation Method to detect canine IgE and kit therefor
FR2765341A1 (fr) * 1997-06-25 1998-12-31 Alain Funes Methode pour l'analyse de l'activation des basophiles humains par mesure de l'expression membranaire du marqueur cd63
AU1727500A (en) * 1998-11-17 2000-06-05 Tanox, Inc. Bispecific molecules cross-linking itim and itam for therapy
WO2001051076A1 (en) * 2000-01-14 2001-07-19 Tanox, Inc. ADMINISTERING IgE ANTAGONISTS DURING PREGNANCY TO AMELIORATE ALLERGIC DISEASES IN THE OFFSPRING
US6889145B1 (en) 2000-03-15 2005-05-03 Northwestern University Three-dimensional model of a Fc region of an IgE antibody and uses thereof
EP1195606A1 (en) * 2000-10-03 2002-04-10 VBC-Genomics Forschungsges.m.b.H. Allergen-microarray assay
DE10110838C2 (de) * 2001-03-06 2003-04-03 Mlu Halle Wittenberg Verfahren zur Diagnostik von Allergien, Pseudoallergien und Intoleranzen
FR2831186B1 (fr) * 2001-10-22 2004-06-18 Aventis Pharma Sa Production d'heparine a partir de cultures de mastocytes
DK1472275T3 (da) 2002-02-05 2009-04-14 Genentech Inc Proteinoprensning
US20060234226A1 (en) 2002-04-26 2006-10-19 Fahner Robert L Non-affinity purification of proteins
SI1648940T1 (sl) 2003-07-28 2016-08-31 Genentech, Inc. Zmanjševanje izluževanja proteina A med afinitetno kromatografijo proteina A
US7613619B1 (en) * 2004-03-30 2009-11-03 Harter Michael R Method for identifying allergens and other influencing agents that may cause a reaction
BRPI0515589A (pt) * 2004-09-02 2008-07-29 Genentech Inc polipeptìdeos ou anticorpos de ligação de antìgeno isolado, anticorpo isolado, método para regular de forma negativa a atividade de fc(gama)riib, métodos de tratamento, anticorpos biespecìficos isolados, métodos de inibição de uma resposta imune, de supressão na liberação de histamina, de ativação de fc(gama)riib, de inibição da expressão do receptor fc(épsilon)ri, composição e kit
US7655229B2 (en) * 2004-09-02 2010-02-02 Chan Andrew C Anti-FC-gamma RIIB receptor antibody and uses therefor
US7662926B2 (en) * 2004-09-02 2010-02-16 Genentech, Inc. Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
ATE505728T1 (de) * 2005-03-16 2011-04-15 Nutricia Nv Verfahren zur bestimmung einer allergischen reaktion
JP2009509124A (ja) * 2005-06-16 2009-03-05 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 大型のパラレルの免疫ベースのアレルギー試験および蛍光のエバネセント場励起のためのデバイス
US20080011058A1 (en) * 2006-03-20 2008-01-17 The Regents Of The University Of California Piezoresistive cantilever based nanoflow and viscosity sensor for microchannels
FR2902799B1 (fr) 2006-06-27 2012-10-26 Millipore Corp Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
PL2087348T3 (pl) * 2006-12-01 2014-09-30 Statens Seruminstitut Sposób przesiewowego badania z zastosowaniem adsorbcji próbki na bibule filtracyjnej
US8163886B2 (en) 2006-12-21 2012-04-24 Emd Millipore Corporation Purification of proteins
US8362217B2 (en) * 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
US8569464B2 (en) 2006-12-21 2013-10-29 Emd Millipore Corporation Purification of proteins
ES2374330T3 (es) 2007-01-22 2012-02-15 Genentech, Inc. Precipitación con polielectrolito y purificación de anticuerpos.
US8191403B2 (en) * 2007-03-27 2012-06-05 Richmond Chemical Corporation Petroleum viscosity measurement and communication system and method
KR20190140090A (ko) 2007-07-09 2019-12-18 제넨테크, 인크. 폴리펩티드의 재조합 생산 동안의 디술피드 결합 환원의 방지
EP3441402A1 (en) 2007-10-30 2019-02-13 Genentech, Inc. Antibody purification by cation exchange chromatography
US8999702B2 (en) * 2008-06-11 2015-04-07 Emd Millipore Corporation Stirred tank bioreactor
FI3604324T3 (fi) 2008-08-14 2024-05-16 Genentech Inc Menetelmiä epäpuhtauden poistamiseksi käyttäen luontaisen proteiinin syrjäytyksen ioninvaihtomembraanikromatografiaa
KR20110076918A (ko) 2008-09-10 2011-07-06 제넨테크, 인크. 단백질의 산화성 분해를 방지하기 위한 조성물 및 방법
EP2358734A1 (en) * 2008-12-16 2011-08-24 Millipore Corporation Purification of proteins
ES2749232T3 (es) 2008-12-16 2020-03-19 Emd Millipore Corp Reactor de tanque agitado y procedimiento
CA2752884A1 (en) 2009-02-27 2010-09-02 Genentech, Inc. Methods and compositions for protein labelling
US10184937B2 (en) * 2009-03-31 2019-01-22 United Arab Emirates University Minimally invasive assessment of IgE mediated allergy
DE102009030845A1 (de) * 2009-06-26 2010-12-30 Siemens Aktiengesellschaft Verfahren und Kit zur Diagnose oder Prognose einer Kontrastmittelallergie
US8512983B2 (en) 2009-08-11 2013-08-20 Martin Gawlitzek Production of proteins in glutamine-free cell culture media
PL2473617T3 (pl) 2009-09-01 2020-06-29 F. Hoffmann-La Roche Ag Ulepszone oczyszczanie białka poprzez zmodyfikowaną elucję z białka A
TR201905081T4 (tr) 2010-03-22 2019-05-21 Hoffmann La Roche Protein içeren formülasyonların stabilizasyonu için yararlı bileşimler ve yöntemler.
BR112012027828A2 (pt) 2010-05-03 2016-08-09 Genentech Inc composição de matéria, artigo de fabricação e método de redução da viscosidade de uma formulação contendo proteína e de preparação de uma formulação aquosa contendo proteína
KR101726707B1 (ko) 2010-05-17 2017-04-13 이엠디 밀리포어 코포레이션 생체분자 정제용 자극 반응성 중합체
HUE030820T2 (en) 2010-05-28 2017-06-28 Hoffmann La Roche Decreasing Lactate Levels and Enhancing Polypeptide Production by Control of Lactate Dehydrogenase and Pyruvate Dehydrogenase Kinase Expression
EP3586826B1 (en) 2010-06-24 2021-05-12 F. Hoffmann-La Roche AG Compositions and methods for stabilizing protein-containing formulations
KR20130100125A (ko) 2010-08-13 2013-09-09 제넨테크, 인크. 질환의 치료를 위한, ＩＬ-1β 및 ＩＬ-18에 대한 항체
WO2012030512A1 (en) 2010-09-03 2012-03-08 Percivia Llc. Flow-through protein purification process
KR102038336B1 (ko) 2011-07-08 2019-10-31 이엠디 밀리포어 코포레이션 일회용 생명공학적 공정용의 개선된 심층 필터
US10364268B2 (en) 2011-12-22 2019-07-30 Genentech, Inc. Ion exchange membrane chromatography
MX365947B (es) 2012-03-27 2019-06-19 Genentech Inc Operaciones de cosecha mejoradas para proteinas recombinadas.
CN104427974B (zh) 2012-05-18 2018-03-23 基因泰克公司 高浓度单克隆抗体配制剂
CA2898146C (en) 2012-12-19 2020-12-01 Charles Andrew BOSWELL Methods and compositions for radiohalogen protein labeling
ES2825574T3 (es) 2014-07-09 2021-05-17 Hoffmann La Roche Ajuste del pH para mejorar la recuperación por descongelación de bancos de células
BR112018070139A2 (pt) 2016-03-29 2019-02-05 Geltor Inc expressão de proteínas em bactérias gram-negativas em que a razão entre o volume periplasmático e o volume citoplasmático é entre 0,5:1 e 10:1
KR102579836B1 (ko) 2016-12-22 2023-09-15 제넨테크, 인크. 동결건조된 폴리펩타이드의 재구성 시간을 감소시키기 위한 방법 및 제제
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
HUE066560T2 (hu) 2018-07-03 2024-08-28 Bristol Myers Squibb Co Rekombináns proteinek elõállítási eljárásai
WO2020076776A1 (en) 2018-10-10 2020-04-16 Boehringer Ingelheim International Gmbh Method for membrane gas transfer in high density bioreactor culture
AU2020254582A1 (en) 2019-04-01 2021-09-30 Genentech, Inc. Compositions and methods for stabilizing protein-containing formulations
TW202104254A (zh) 2019-04-12 2021-02-01 美商格爾托公司 重組彈性蛋白及其生產
KR20220039777A (ko) 2019-08-01 2022-03-29 브리스톨-마이어스 스큅 컴퍼니 유가식 세포 배양에서 단백질 생산성을 개선시키는 방법
WO2022066595A1 (en) 2020-09-22 2022-03-31 Bristol-Myers Squibb Company Methods for producing therapeutic proteins
CN113495139A (zh) * 2021-07-07 2021-10-12 上海清芮科技有限公司 一种宠物特应性体质的检测方法
WO2023015234A1 (en) 2021-08-05 2023-02-09 Bristol-Myers Squibb Company Cell culture methods for producing therapeutic proteins
WO2023049687A1 (en) 2021-09-21 2023-03-30 Bristol-Myers Squibb Company Methods of controlling the level of dissolved oxygen (do) in a solution comprising a recombinant protein in a storage container

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559310A (en) * 1983-05-20 1985-12-17 Dana Farber Cancer Institute Assay methods and systems utilizing mast cell clones
US4946788A (en) * 1985-06-11 1990-08-07 Ciba-Geigy Corporation Purified immunoglobulin-related factor, novel monoclonal antibodies, hybridoma cell lines, processes and applications
DE3777245D1 (de) * 1986-04-30 1992-04-16 Junji Yodoi Protein und verfahren zu dessen herstellung.
US5180805A (en) * 1986-07-02 1993-01-19 Research Corporation Limited Polypeptide competitor for immunoglobulin E
GB8727045D0 (en) * 1987-11-19 1987-12-23 Research Corp Ltd Immunoglobulin e competitor
US4962035A (en) * 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof
JPH03127997A (ja) * 1989-10-11 1991-05-31 Kuraray Co Ltd ヒト１ｇＥ結合因子に特異的なモノクローン抗体、それを産生するハイブリドーマおよびその用途
CA2059842A1 (en) * 1991-02-11 1992-08-12 Richard A. Chizzonite Ige-receptor-antibodies
AU2917992A (en) * 1991-12-05 1993-06-28 Board Of Regents Of The University Of Nebraska, The Allergen specific immunoglobulin-e producer test for diagnosing allergies
GB9224956D0 (en) * 1992-11-28 1993-01-20 Euro Dpc Ltd Improvements relating to allergen testing & apparatus

Also Published As

Publication number Publication date
ES2108566T3 (es) 1997-12-16
US5714338A (en) 1998-02-03
GR3025089T3 (en) 1998-01-30
DE69405251T2 (de) 1998-02-05
JP3507852B2 (ja) 2004-03-15
WO1995016203A2 (en) 1995-06-15
ATE157455T1 (de) 1997-09-15
JPH09506435A (ja) 1997-06-24
CA2176811A1 (en) 1995-06-15
WO1995016203A3 (en) 1995-06-29
DE69405251D1 (de) 1997-10-02
CA2176811C (en) 2008-01-29
EP0733207B1 (en) 1997-08-27
EP0733207A1 (en) 1996-09-25

Similar Documents

Publication Publication Date Title
DK0733207T3 (da) Fremgangsmåder til diagnose af allergi og screening af anti-allergi-terapeutika
Slota et al. ELISpot for measuring human immune responses to vaccines
Chin et al. Mobile device for disease diagnosis and data tracking in resource-limited settings
Tighe et al. Improving the quality and reproducibility of flow cytometry in the lung. An official American Thoracic Society workshop report
Beeler et al. CD69 upregulation on T cells as an in vitro marker for delayed‐type drug hypersensitivity
Khanna et al. Recommendations for screening and detection of connective tissue disease–associated pulmonary arterial hypertension
Tanaka et al. Multiparameter flow cytometric approach for simultaneous evaluation of proliferation and cytokine‐secreting activity in T cells responding to allo‐stimulation
Nicoll et al. The public health applications of unlinked anonymous seroprevalence monitoring for HIV in the United Kingdom
Armah et al. Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study
Kubota et al. Sulfidoleukotriene release test (CAST) in hypersensitivity to nonsteroidal anti-inflammatory drugs
Choquet-Kastylevsky et al. Drug allergy diagnosis in humans: possibilities and pitfalls
Abraham et al. Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopenia
Gujar et al. Flow cytometric quantification of T cell proliferation and division kinetics in woodchuck model of hepatitis B
Martin et al. Predicting and diagnosing abacavir and nevirapine drug hypersensitivity: from bedside to bench and back again
Nolte The clinical utility of basophil histamine release
HUP0104712A2 (hu) Eljárás specifikus IgE-ellenanyag kimutatására és/vagy mennyiségi meghatározására folyékony mintában
Kimura Positive ratio of allergen specific IgE antibodies in serum, from a large scale study
Lee et al. Multi-Factor Clustering Incorporating Cell Motility Predicts T Cell Expansion Potential
Granade Use of rapid HIV antibody testing for controlling the HIV pandemic
Tripathy et al. Cytokine levels in Chandipura virus associated encephalopathy in children
WO2005034736A3 (en) Generation of biochemical images and methods of use
Essop Enhancing the usability of a university student support services FAQ Chatbot
Enomoto et al. High-throughput miniaturized immunoassay for human interleukin-13 secreted from NK3. 3 cells using homogenous time-resolved fluorescence
Barron et al. Diabetes mellitus is associated with increased prevalence of latent tuberculosis infection: Results from the National Health and Nutrition Examination Survey
Montoya et al. In vitro characterisation and clinical evaluation of the diagnostic accuracy of a new antigen test for SARS-CoV-2 detection